The European Trauma Course: Transforming systems through training.

The European Trauma Course (ETC) exemplifies an innovative approach to multispecialty trauma education. This initiative was started as a collaborative effort among the European Society for Emergency Medicine, the European Society for Trauma and Emergency Surgery, and the European Society of Anaesthesiology under the auspices of the European Resuscitation Council. With the robust support of these societies, the project has evolved into the independent European Trauma Course Organisation.

Idarucizumab for dabigatran reversal in daily clinical practice: A case series.

Background: Real-life experience with idarucizumab, which reverses the anticoagulant effect of dabigatran, is currently limited.

Objective: To evaluate efficacy and safety of the clinical use of idarucizumab after its availability in Slovenia.

Methods: We analysed consecutive cases treated with idarucizumab in Slovenia from January to October 2016.